Therakos Overview

  • Year Founded
  • 1984

Year Founded

  • Status
  • Private

  • Employees
  • 178

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

Therakos General Information

Description

Provider of extracorporeal photopheresis immune modulation therapy intended to help enhance immunologic response. The company specializes in the treatment of skin symptoms of mycosis and the treatment decisions can incorporate the disease stage, overall prognosis, patient quality of life, and most bothersome symptoms, thereby helping patients to cure themselves.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 3 Lotus Park
  • The Causeway
  • Staines-upon-Thames TW18 3AG
  • England, United Kingdom
Primary Industry
Drug Delivery
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • 3 Lotus Park
  • The Causeway
  • Staines-upon-Thames TW18 3AG
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Therakos Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Therakos‘s full profile, request access.

Request a free trial

Therakos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of extracorporeal photopheresis immune modulation therapy intended to help enhance immunologic response. The co
Drug Delivery
Staines-upon-Thames, United Kingdom
178 As of 2015

Paterna, Spain
 

Madison, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Therakos Competitors (8)

One of Therakos’s 8 competitors is Igenomix USA, a Formerly PE-Backed company based in Paterna, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Igenomix USA Formerly PE-Backed Paterna, Spain
Exact Sciences Formerly VC-backed Madison, WI
Biocept Formerly VC-backed San Diego, CA
Natera Formerly VC-backed Austin, TX
Stemedica Venture Capital-Backed San Diego, CA
You’re viewing 5 of 8 competitors. Get the full list »

Therakos Patents

Therakos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10335452-B2 Method of treating patients with hepatorenal syndrome type 1 Active 24-Oct-2014
US-20160113994-A1 Method of treating patients with hepatorenal syndrome type 1 Active 24-Oct-2014
US-20200046798-A1 Method of treating patients with hepatorenal syndrome type 1 Inactive 24-Oct-2014
US-10758703-B2 Systems and methods for providing a pulse of a therapeutic gas with a desired flow profile to maximize therapeutic effectiveness Active 17-Oct-2014
US-20160106949-A1 Systems and methods for providing a pulse of a therapeutic gas with a desired flow profile to maximize therapeutic effectiveness Active 17-Oct-2014 A61M16/208
To view Therakos’s complete patent history, request access »

Therakos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Therakos Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Therakos‘s full profile, request access.

Request a free trial

Therakos FAQs

  • When was Therakos founded?

    Therakos was founded in 1984.

  • Where is Therakos headquartered?

    Therakos is headquartered in Staines-upon-Thames, United Kingdom.

  • What is the size of Therakos?

    Therakos has 178 total employees.

  • What industry is Therakos in?

    Therakos’s primary industry is Drug Delivery.

  • Is Therakos a private or public company?

    Therakos is a Private company.

  • What is the current valuation of Therakos?

    The current valuation of Therakos is .

  • What is Therakos’s current revenue?

    The current revenue for Therakos is .

  • How much funding has Therakos raised over time?

    Therakos has raised $40.6M.

  • Who are Therakos’s investors?

    CVC Capital Partners has invested in Therakos.

  • Who are Therakos’s competitors?

    Igenomix USA, Exact Sciences, Biocept, Natera, and Stemedica are some of the 8 competitors of Therakos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process